These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 24998569

  • 1. Genotype distribution of human papillomavirus in women with abnormal cervical cytology in an esophageal carcinoma high incidence area of China.
    Mai RQ, Huang B, Shen L, Zhang GH, Hong LL, Cai YM.
    Asian Pac J Cancer Prev; 2014; 15(12):4945-50. PubMed ID: 24998569
    [Abstract] [Full Text] [Related]

  • 2. Genotype Distribution of Human Papillomavirus among Women with Cervical Cytological Abnormalities or Invasive Squamous Cell Carcinoma in a High-Incidence Area of Esophageal Carcinoma in China.
    Wang Y, Wang S, Shen J, Peng Y, Chen L, Mai R, Zhang G.
    Biomed Res Int; 2016; 2016():1256384. PubMed ID: 27610364
    [Abstract] [Full Text] [Related]

  • 3. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A, Hebette G, Fischer M, Arbyn M, Weyers S, Vielh P, Schmitt F, Mossong J.
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [Abstract] [Full Text] [Related]

  • 4. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
    Khunamornpong S, Settakorn J, Sukpan K, Srisomboon J, Suprasert P, Siriaunkgul S.
    Asian Pac J Cancer Prev; 2014 May; 15(24):10961-6. PubMed ID: 25605209
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study.
    Wu EQ, Liu B, Cui JF, Chen W, Wang JB, Lu L, Niyazi M, Zhao C, Ren SD, Li CQ, Gong XZ, Smith JS, Belinson JL, Liaw KL, Velicer C, Qiao YL.
    Cancer Causes Control; 2013 Apr; 24(4):795-803. PubMed ID: 23397310
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and carcinogenic risk of high-risk human papillomavirus subtypes in different cervical cytology: a study of 124,251 cases from the largest academic center in China.
    Tao X, Zhang H, Wang S, Chen T, Cong Q, Wang L, Zhou X, Zhao C.
    J Am Soc Cytopathol; 2021 Apr; 10(4):391-398. PubMed ID: 33906830
    [Abstract] [Full Text] [Related]

  • 7. Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program.
    Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LC, Cuzick J, Myers O, Castle PE, Wheeler CM, New Mexico HPV Pap Registry Steering Committee.
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):36-42. PubMed ID: 26518316
    [Abstract] [Full Text] [Related]

  • 8. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K.
    Cancer; 2006 Mar 01; 106(5):1054-64. PubMed ID: 16421920
    [Abstract] [Full Text] [Related]

  • 9. Investigation of Transition Types of HPV DNA Test Results over Time in Korean Women.
    Ko K, Kwon MJ, Woo HY, Park H.
    Asian Pac J Cancer Prev; 2015 Mar 01; 16(8):3167-72. PubMed ID: 25921116
    [Abstract] [Full Text] [Related]

  • 10. Comparative analysis of cervical cytology and human papillomavirus genotyping by three different methods in a routine diagnostic setting.
    Padalko E, Ali-Risasi C, Mesmaekers S, Ryckaert I, Van Renterghem L, Lambein K, Bamelis M, De Mey A, Sturtewagen Y, Vastenavond H, Broeck DV, Weyers S, Praet M.
    Eur J Cancer Prev; 2015 Sep 01; 24(5):447-53. PubMed ID: 25370681
    [Abstract] [Full Text] [Related]

  • 11. Health disparities in cervical cancer: Prevalence of high-risk HPV and cytologic diagnoses according to race.
    Miller D, Morris CP, Maleki Z, White M, Rodriguez EF.
    Cancer Cytopathol; 2020 Nov 01; 128(11):860-869. PubMed ID: 32598100
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of human papillomavirus genotypes in cytologic abnormalities from unvaccinated women living in north-western Spain.
    Otero-Motta AP, Ordóñez JL, González-Celador R, Rivas B, Macías Mdel C, Bullón A, Abad Mdel M.
    APMIS; 2011 Mar 01; 119(3):204-15. PubMed ID: 21284738
    [Abstract] [Full Text] [Related]

  • 13. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
    Pan QJ, Hu SY, Guo HQ, Zhang WH, Zhang X, Chen W, Cao J, Jiang Y, Zhao FH, Qiao YL.
    Gynecol Oncol; 2014 May 01; 133(2):172-9. PubMed ID: 24631450
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and viral load of 51 genital human papillomavirus types and three subtypes.
    Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M, VALGENT Study Group.
    Int J Cancer; 2013 May 15; 132(10):2395-403. PubMed ID: 23034864
    [Abstract] [Full Text] [Related]

  • 15. The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China.
    Zhang J, Zhang D, Yang Z, Wang X, Wang D.
    BMC Cancer; 2020 May 19; 20(1):443. PubMed ID: 32429919
    [Abstract] [Full Text] [Related]

  • 16. Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.
    Zhao FH, Zhu FC, Chen W, Li J, Hu YM, Hong Y, Zhang YJ, Pan QJ, Zhu JH, Zhang X, Chen Y, Tang H, Zhang H, Durand C, Datta SK, Struyf F, Bi D, HPV-039 study group.
    Int J Cancer; 2014 Dec 01; 135(11):2604-11. PubMed ID: 24740547
    [Abstract] [Full Text] [Related]

  • 17. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Wang JJ, Dong J, Deng ZX, Wang PF, Zhang XX, Du Y.
    Zhonghua Fu Chan Ke Za Zhi; 2019 May 25; 54(5):301-306. PubMed ID: 31154710
    [Abstract] [Full Text] [Related]

  • 18. Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings.
    Li Y, Ye F, Lü WG, Zeng WJ, Wei LH, Xie X.
    Int J Gynecol Cancer; 2010 May 25; 20(4):631-7. PubMed ID: 20686384
    [Abstract] [Full Text] [Related]

  • 19. Expression of p16/Ki-67 in ASC-US/LSIL or Normal Cytology with Presence of Oncogenic HPV DNA.
    Solares C, Velasco J, Álvarez-Ruiz E, González-Fernández L, Encinas AI, Astudillo A, Schneider J.
    Anticancer Res; 2015 Nov 25; 35(11):6291-5. PubMed ID: 26504065
    [Abstract] [Full Text] [Related]

  • 20. Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection.
    Nieves L, Enerson CL, Belinson S, Brainard J, Chiesa-Vottero A, Nagore N, Booth C, Pérez AG, Chávez-Avilés MN, Belinson J.
    Int J Gynecol Cancer; 2013 Mar 25; 23(3):513-8. PubMed ID: 23334437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.